A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 150 shares of GILD stock, worth $13,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$13,212
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$63.15 - $72.88 $9,472 - $10,932
150 New
150 $10,000
Q3 2023

Nov 01, 2023

SELL
$73.94 - $80.67 $695,109 - $758,378
-9,401 Closed
0 $0
Q2 2023

Jul 31, 2023

SELL
$76.01 - $86.7 $94,176 - $107,421
-1,239 Reduced 11.64%
9,401 $724,000
Q1 2023

May 01, 2023

BUY
$77.31 - $88.08 $213,298 - $243,012
2,759 Added 35.01%
10,640 $882,000
Q4 2022

Jan 31, 2023

SELL
$62.32 - $89.47 $5,421 - $7,783
-87 Reduced 1.09%
7,881 $676,000
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $21,077 - $24,075
-354 Reduced 4.25%
7,968 $492,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $6,637 - $7,476
-115 Reduced 1.36%
8,322 $515,000
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $16,623 - $20,830
287 Added 3.52%
8,437 $502,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $165,119 - $187,413
2,545 Added 45.41%
8,150 $592,000
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $379,402 - $409,333
5,605 New
5,605 $392,000
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $870,875 - $957,934
-14,133 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $883,453 - $975,177
14,133 New
14,133 $896,000
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $1.88 Million - $2.19 Million
-28,930 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $662,844 - $808,080
9,100 Added 45.89%
28,930 $2.18 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $1.43 Million - $1.69 Million
19,830
19,830 $1.61 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.